Abbreviations used in this manuscript: DOPE = L-α dioleoyl phosphatidylethanolamine, DOTAP = 1,2-bis(dioleoyloxy)-3-(trimethylamonio)propane, LNP = lipid nanoparticle; PCL = poly(cationic lipid), NMR= Nuclear magnetic resonance; PLNP = polylipid nanoparticles, DVDM = DeltaVision deconvolution microscope.
INTRODUCTION
Lipid nanoparticles (LNP) have been used widely for in vitro gene delivery, however, their albeit potential for in vivo gene delivery has been hampered by stability issues in the bloodstream, poor targeting efficiency and transient transfection efficacy.(1) Polylipid nanoparticles (PLNP), formulated from polycationic lipid (PCL) and cholesterol, on the other hand, have been documented to be more stable than DOTAP-DOPE or DOTAP-cholesterol formulations in the bloodstream.(2) We have also shown that PLNP-derived polyplexes were effective in delivering reporter genes, human antioxidative genes (extracellular superoxide dismutase (EC-SOD) or catalase) to the liver for the treatment of acute liver injury caused by hepatotoxins or an ischemia/reperfusion procedure in two separate preclinical model systems.(3, 4) These studies suggest that PLNP are a very effective gene transfer agent for liver-based delivery, and have great potential to move from small animals to large animal trials as a step towards clinical applications.(5) To develop an even more biocompatible gene delivery agent and to move this antioxidative gene approach from "bench to bedside", in-depth characterization of PCL, PLNP and polyplexes, as well as a feasible technologies for larger-scale synthesis of PCL are needed. In this study, we employ state-of-the-art technologies, such as Raman microspectroscopy, mass spectrometry and DeltaVision deconvolution microscopy (DVDM) for live cell imaging together with Zeta potential measurements to further characterize PCL, PLNP and PLNP-derived polyplexes. These novel technologies enable us to characterize the physicochemical features of PCL, PLNP, PLNP-derived polyplexes, as well as the lipofection process, and further determine the stability of the polyplexes. We also describe modifications to our original method of PCL synthesis that enable multigram preparations of PCL sufficient for large animal experiments.
EXPERIMENTAL PROCEDURES 1. Synthesis of PCL
(1) Synthetic Procedures and Validation. PCL (1) was prepared according to the synthetic route outlined in Fig. 1 . Prior to use, CH 2 Cl 2 was immediately distilled from CaH 2 . After reaction work-up, solutions were dried using Na 2 SO 4 and solvents were subsequently removed by rotary evaporation. Nuclear magnetic resonance (NMR) spectra were recorded with a General Electric QE-300 spectrometer ( 1 H at 300 MHz, 13 C at 75 MHz). Infrared spectra were recorded on a Mattson Genesis II FTIR 3000 spectrometer. Melting points are uncorrected. Elemental analyses were performed by Midwest Microlabs (Indianapolis, IN). All sonications were performed in a bath sonicator (Laboratory Supplies Inc., Hicksville, NY).
(2) 3-Bromo-1, 2-bis(tetradecanoyloxy)propane (3). To a solution of 3-bromo-1,2-propane-diol (2) (9.20 g, 59.4 mmol) in CH 2 Cl 2 (50 mL) were added triethylamine (16.5 mL, 119 mmol) and 4-(N,N-dimethylamino)pyridine (400 mg). The reaction mixture was cooled to 0 °C, and then myristoyl chloride (40.4 mL, 149 mmol) was added drop-wise. The reaction was warmed to room temperature and quenched after 4 hours by pouring over saturated aqueous NaHCO 3 (100 mL). The aqueous layer was separated and the organic layer was washed successively with saturated aqueous NaHCO 3 , water, and brine, and then dried (Na 2 SO 4 ). The solvents were concentrated in vacuum, the crude residue was dissolved in ethanol, and minimal water was added to provide a cloudy suspension. The solution was placed in the freezer overnight causing bromodiester 3 to precipitate as a white solid (31.4 g, 54.6 mmol, 92%); mp 40-41. 
To a solution of bromo diester 3 (23.9 g, 42.8 mmol) in N,Ndimethylformamide (200 mL) was added N,N'-dimethylethylenediamine (DMF) (36.8 mL, 342 mmol) via a syringe. The reaction was stirred under an argon atmosphere at 70 °C. After stirring 45 min, DMF and the unreacted diamine were removed by vacuum distillation. The residue was suspended in CH 2 Cl 2 (250 mL) and washed successively with saturated aqueous NaHCO 3 , water, and brine, and then dried (Na 2 SO 4 ). The solvent was removed and the crude product was passed through a short column of silica gel, eluting with 15% MeOH/CH 2 Cl 2 , to afford the crude diamino diester as yellow oil (9.6 g).
To a solution of the crude diamino diester (9.6 g, 16.5 mmol) in CH 2 Cl 2 (100 mL) at 0 °C were added triethylamine (2.3 mL, 16 mmol) and 4-(N,N-dimethylamino)pyridine (200 mg). Acryloyl chloride (1.6 mL, 25 mmol) was added drop-wise to the resulting solution and the reaction mixture was warmed to room temperature. After stirring 3 hours, the reaction was quenched by pouring over saturated aqueous NaHCO 3 . The layers were separated and the organic layer was washed with water and brine, dried (Na 2 SO 4 ), and then concentrated by rotary evaporation. The residue was purified by column chromatography (SiO 2 ), eluting with a 3:2 mixture of EtOAc: hexane, to give the diester acrylamide 4 as a light yellow oil (8.72 g, 13 (5) The final product, PCL (1). Monomer 5 (4.32 g, 6.28 mmol) was suspended in nanopure water (400 ml) by sonication at 50 °C for 45 min. The resultant homogeneous suspension was degassed by bubbling a stream of nitrogen through the suspension for 20 min. The suspension then was heated to 80 °C and stirred vigorously while adding n-dodecyl mercaptan (432 mg, 2.13 mmol) followed by a solution of 2,2'-azobis(2-methylpropionamidine) dihydrochloride (AAPH) (175 mg in 45 mL H 2 O, 0.645 mmol). The resulting mixture was stirred at 80 °C for 15 hours, after which the reaction vessel was placed in a freezer overnight (-10 °C). After thawing at room temperature, the precipitated solids were filtered, and washed successively with cold diethyl ether to remove trace mercaptan and then dried under vacuum to afford PCL (4.21g, 97%) as a white solid with spectral characterization identical to that previously reported.(6) 2. Mass spectral analysis of PCL PCL (5 mg) was dissolved in 1 mL of isopropanol. Both a 0.17 M solution of paranitroaniline (PNA) and a 0.5 M solution of 2,5-dihydroxybenzoic acid (DHB) were prepared in isopropanol and used as matrices. PNA has been used previously for the detection of phospholipids in positive-and negative-ion spectra.(7) A 1-µL aliquot of the analytical solution was spotted in each of five different sample wells of 100-spot stainless steel MALDI plate (Applied Biosystems, Foster City, CA). The matrix (1 µL) was then added on top of each sample spot (dried droplet method). After crystallization at ambient conditions, mass spectra were recorded on a Voyager Biospectrometry DE workstation (Applied Biosystems, Foster City, CA) equipped with a Nitrogen laser (λ = 337 nm). The extraction voltage was set to 20 kV. Mass spectra were acquired in both positive and negative modes.
Raman micro-microscopy analysis of PCL, PLNP and PLNP-derived polyplexes
The Raman spectra of various LNP formulations were acquired using a Laser-Tweezers Raman micro-spectroscopy system, which is custom-built around a commercial inverted microscope platform.(8) The main microscope frame consists of an Olympus IX-71 microscope, utilizing a 60x, NA 1.2, water immersion objective optimized for near-IR operation. The laser source is an 80 mW, 785 nm diode-pumped solid-state laser, resulting in ~30 mW laser power in the microscope focus after passing multiple mirrors, a bandpass filter, and the microscope objective. The laser beam is focused to a diffraction-limited laser spot of ~500 nm diameter. The microscope is equipped with a mercury arc lamp for white-light fluorescence excitation through appropriate filters, as well as differential interference contrast for visualizing cells. Laser trapping and fluorescence excitation can be performed simultaneously. Spectroscopy is performed through an attached SP2300i spectrograph (Acton Research Corporation) and a backilluminated thermoelectrically-cooled deep-depletion CCD camera with 1340x1000 pixels (Fig.  2) .
The use of a fluorescence deconvolution microscopy system to monitor the lipofection process
The automated fluorescence deconvolution microscopy system (9) (Personal DV, Applied Precision, LLC., Issaquah, WA) makes use of an Olympus IX-71 inverted optical microscope with a 250W Xenon illumination source, a 60x oil-immersion objective lens with a numerical aperture (N.A.) of 1.4 and a precision stepper-motor driven XYZ stage. The microscope is equipped with DAPI, FITC, TRITC, CY3, and CY5 filter sets, as well as 5 neutral density filters for the excitation source. It is capable of exciting fluorophores from the UV to the far red and also collects transmitted light (bright field, differential interference contrast (DIC)) images. Image capture is achieved with a CoolSnap ES2 (Photometrics, Tucson, AZ) -a fast, high resolution, high quantum efficiency, thermoelectrically cooled CCD camera. It can be used for both slow scan, high resolution imaging of fixed samples or fast, high sensitivity image capture of live cell samples.
The DeltaVision acquisition, image processing and analysis software (softWoRx 3.7.0) run on a dual processor personal computer running Cent OS Linux. The microscope is capable of separating up to 4 dyes and displaying triply labeled samples in a single image window through false colors. The DeltaVision software package automates the deconvolution computations, generates 3D reconstructions, and enables autofocusing, cell tracking, and live-cell imaging.
In our experiment, Hep G 2 cells were seeded on 35 mm diameter round glass bottom culture dishes (MatTek Corp., Ashland, MA). The next day, cells were transfected with plasmid pEGFP-C1 by either PLNP or Lipofectamine, and then incubated at 37ºC. At specified time points, the culture dishes were mounted on the DeltaVision Deconvolution microscope. The temperature of the microscope stage was kept constant at 37ºC using an air-stream incubator (ASI-400, NevTek, Williamsburg, VA). GFP fluorescence of Hep G 2 cells was detected using a standard FITC filter set and corresponding bright field images were also collected. A series of images at different vertical focus positions resulting in optical sections (step size 0.1 µm) were captured with an image size of 512 by 512 pixels and setting binning to 2x2. The exposure time of between 0.1 to 0.3 seconds was sufficient to obtain images suitable for the dynamic range of the cooled CCD camera. Images were saved and processed using the DeltaVision software package (softWoRx 3.7.0) and Adobe Photoshop CS3.
Zeta potential of PCL, PLNP and polyplexes
PLNPs were generated as reported previously and complexed with plasmid DNA at different charge ratios. The size distribution was determined by laser light scattering as reported previously (10) . PLNPs or polyplexes in 2 μL were suspended in 2.5 mL water, and their Zeta potentials were determined at room temperature in a Zeta Potential/Particle Sizer Nicomp TM 280 ZCS PSS-Nicomp Particle Sizing System (Santa Barbara, CA).
Statistical analysis
The data of Zeta potential in different charge ratios were analyzed by one way variance test followed by multiple comparisons between groups with Newman-Keuls test. A p-value of less than 0.05 was considered as statistically significant.
RESULTS

Synthesis of PCL in a multi-gram quantity
The PCL synthesis proceeded from commercially available diol 2 by bisesterification using myristoyl chloride. Subsequent bromide displacement by N, N'-dimethylethylenediamine followed by reaction of the crude adduct with acryloyl chloride gave acrylamide 4. Amine quaternization followed by counterion exchange using an established procedure (11) afforded acrylamide 5 as the chloride salt. The polymerization of 5 was accomplished by heating a suspension of 5 in water (ca. 15 mM) to 80°C and then adding n-dodecyl mercaptan (12) and the water-soluble free radical initiator 2,2'-azobis(2-methylpropionamidine) dihydrochloride (AAPH). (13) The delay in addition of n-dodecyl mercaptan until the formulation of lipid nanoparticle with 5 differs from our previous protocol (6) and helps minimize conjugate addition of the thiol to the acrylamide. All intermediate products were validated by NMR spectral analysis, and the final polymeric product was determined in both negative and positive modes by mass spectral analysis (MALDI-TOF MS). The strongest MALDI-TOF MS signals were obtained with the use of para-nitroaniline (PNA) as the matrix. Although no detectable peaks were obtained in the negative mode, strong signals with maximal intensity at m/z = 651.6 were observed in positive-ion spectra, consistent with a polymeric product derived from monomer 5 (Fig. 3) . The product arising from conjugate addition of dodecyl mercaptan to the acrylamide moiety of 5 was observed at m/z = 853.6. Thus, our modified synthetic method produced PCL in multi-gram quantities, which is essential for generating enough PLNP for experiments in large animals.
Raman spectroscopic analysis of PCL, PLNP and PLNP-derived polyplexes
We have obtained Raman spectra of the various starting materials at high concentration, such as plasmid DNA (3.6 µg/µl), pure Lipofectamine and pure cholesterol as received from the manufacturer, as well as unformulated PCL as synthesized (Fig. 4A) . For comparison, spectra of Lipofectamine complexes with plasmid DNA (Fig. 4B) , as well as those of PCL vesicles, PLNP, and PLNP-derived polyplexes were taken (Fig. 4C) . The Raman data from unformulated PCL are due to Raman scattering on carbon-bonds, i.e. C-C, C=C, C-H, CH 2 , and clearly show the polymeric nature of PCL. (14, 15) The most prominent peaks are C-C stretch modes in the 1100-1200 cm -1 and the 1300 cm -1 range, and the 1445 cm -1 methylene bending vibration in the polymer. Similar features with less pronounced peaks besides the 1445 cm -1 methylene deformation mode were found for Lipofectamine and cholesterol. Cholesterol contains an additional strong C=C vibration at ~1670 cm -1 . The spectrum of plasmid DNA (Fig. 4A) (Fig. 4B) . Raman spectra were acquired from individual optically trapped PCL, PLNPs, and PLNP polyplex vesicles within a 30s signal integration time. Interestingly, PCL changes its spectrum between unformulated PCL and formulated PCL nanoparticles. Most notable is the addition of a strong 1001 cm -1 C-H out-of-plane deformation mode. C-H and C-C modes in this spectral range are known to be sensitive markers of acyl chain disorder. (8, 14) This has been widely observed in lipid vesicles. Based on these observations we attribute this strong peak to the increased chain disorder in formulated PCL when compared to unformulated PCL powder. Interestingly, the addition of cholesterol to PCL nanoparticles to form PLNP does not noticeably change the Raman spectrum of these particles, i.e. the disordered state of the polymer chains is retained in the presence of cholesterol. PLNP-derived polyplexes undergo a marked change in their Raman spectrum when compared to PLNP. Here, the 1001 cm -1 C-H outof-plane deformation mode is significantly suppressed due to interaction with plasmid DNA. We attribute this to strong interactions of the charged DNA backbone with the charged polymer chains, which apparently leads to strong ordering in the vesicle chain structure (Fig. 4C) . The presence of DNA in polyplexes is further confirmed by the presence of weak DNA markers, such as the 785 cm -1 cytosine breathing mode, the 1090 cm -1 phosphate vibration, and the 1660 cm -1 amide I mode.
Use of fluorescence deconvolution microscopy to dynamically monitor reporter gene expression
To dynamically determine the earliest expression of a reporter gene, enhanced green fluorescent protein (GFP), we employed a fluorescence microscopy imaging system for timelapsed live cell imaging to compare the transfection efficiency of PLNP with Lipofectamine. As shown in Fig. 5 , the earliest GFP expression in Hep G 2 cells was seen 60 min after PLNPmediated transfection with a pEGFP-C1-EGFP plasmid at the charge ratio of 5:1 (Fig. 5A,D) , while focal and faint GFP expression was also seen in Hep G 2 cells 70 min after Lipofectamine transfection (Fig. 5G, J) , indicating that lipid nanoparticle-mediated plasmid DNA entering a cell and the nucleus, i.e. the transcription of the reporter gene, is a rather fast process. GFP expression then became more intense and spread throughout Hep G 2 cells transfected either with PLNP ( Fig. 5 B, C, E, F) or Lipofectamine (Fig. 5H, I, K, L) . This observation indicates that the transfection efficiency of PLNP is at least as good as Lipofectamine in Hep G 2 cells. Moreover, the use of the DVDM system enables us to section cells at 0.1 μm thicknesses, and a 3 dimentional structure of a cell can be built from the sections at the Z axis. The supplemental figure shows 3 dimentional GFP images of Hep G 2 cells at different Z-section levels after either PLNP or Lipofectamine transfection at 210 and 230 min. With the DVDM system, it is possible to investigate which subcellular organelles are involved in the lipofection process in a live cell, when a specific dye is used to label lysosomes, endosome, mitochondria or endoplasmic reticulum.
Zeta potential, charge ratios, and visualization of PLNP and polyplexes
In order to further determine the relationship of charge ratios and Zeta potential of PLNP and PLNP-derived polyplexes, we mixed PLNP with plasmid DNA at various charge ratios, and measured the Zeta potential of PLNP and PLNP-derived polyplexes. It is clear from Fig. 6 that for in vitro transfection at a charge ratio of 5:1, the Zeta potential of polyplexes was slightly lower than PLNP without DNA (p>0.05). For in vivo gene delivery at the charge ratio of 1.25:1, the Zeta potential of the polyplexes was negative (-6.46 ± 0.97 mV), which is consistent with them being less reactive to serum proteins as reported previously.(2). The stability of our PLNP was further confirmed in vitro when PCL and PLNP vesicles were prepared by sonication to result in nanoparticles with a diameter of 149 ± 62nm. Under the microscope we were able to visualize the vesicles of both PCL and PLNP by their absorption of transmitted light (highlighted by a circle) (Fig. 7A) . The vesicles appear homogenous in size and shape. The morphology of these particles did not change after complexation with plasmid DNA (Fig. 7B) , whereas Lipofectamine formed large aggregates in the presence of plasmid DNA (4 μl liposomes/2μg DNA) (Fig. 7C) . These data indicate that our PLNP formulation is superior to Lipofectamine in DNA binding capacity and particle stability when forming complexes with plasmid DNA.
DISCUSSION
In our previous study, a cationic acrylamide lipid was polymerized to form PCL.(6) Our PLNP formulated from PCL and cholesterol have been considered as one of a few non-viral lipid nanoparticle formulations (18, 19) useful for in vivo gene transfer due to their non-toxic feature, high stability in the bloodstream, and superior transfection efficacy in mouse liver.(2, 6) The preclinical proof-of-concept experiments in two separate model systems demonstrated that the delivery of antioxidative genes, either EC-SOD, catalase or in combination protected mouse from acute liver injury induced by hepatotoxins or hepatic ischemia/reperfusion procedures.(3, 4) These studies were highlighted as "the basis for studies with larger animals and may help bridge the gap between the basic understanding of pathophysiologic processes in animal models towards a practical clinical application in liver transplantation".(5) In order to perform large animal experimentation, such as in pigs or non-human primates, or for clinical use, we developed a feasible synthetic route for synthesizing PCL on a relatively large scale. The purity of the final product with the polymeric features was verified by mass spectrometry; and PLNP were formulated with the final product, and used in the experiments of this study.
Raman spectroscopy is a laser-based analytical technique that enables chemical characterization of molecules in microscopically small samples.(8) Raman micro-spectroscopy is based on the inelastic scattering of photons by molecular bond vibrations and is a useful tool for the chemical analysis of lipids, lipoplexes or polyplexes due to its ability to provide chemical group identification. (20) A particular advantage of micro-Raman spectroscopy is its unrivaled sensitivity and its relative non-invasiveness, which enables the non-destructive analysis of nanoscopic compounds as small as 50 nm diameter. (8, 14) We have employed Raman microspectral analysis in a number of studies (21, 22) , including analyzing the chemical composition of individual triglyceride-rich lipoproteins (23) . A Raman spectrum appears when a small portion of the photons from a monochromatic light source is scattered by interaction with the bonds resulting in a shift toward higher or lower frequencies. The energy difference between the incident and scattered photons corresponds to the vibrational energy of the specific molecular bond interrogated. A Raman spectrum obtained from lipids, DNA or their complexes provides an intrinsic molecular fingerprint of these samples, and reveals characteristic information about macromolecular conformations.(8) In order to further characterize the chemical features of PCL, PLNP and PLNP-derived polyplexes, we employed a laser-tweezers Raman micro-spectroscopy system to observe morphologic changes in these particles after complexation with plasmid DNA and to acquire Raman spectra of polyplexes and compare them with Lipofectamine lipoplexes. After carefully comparing with pure reagents for PLNP formulation and polyplex formation, we found that the Raman spectra of PCL exhibits polymeric characteristics of the synthetic polymer;
and that the spectra of PLNP indicate that they readily interacted with plasmid DNA and formed complexes without aggregation. Lipofectamine, on the other hand, was observed to form large aggregates devoid of specific interactions with DNA after complexation with plasmid DNA. These findings, which have not been reported, imply the feasibility of in vivo application of PLNP.
The appearance and extent of reporter gene expression in transfected cells are generally determined either by measuring activity of luciferase after lysing cells or by observing the onset of fluorescence from GFP expression at certain time points with a regular fluorescent microscope. It is generally believed that the lipofection process usually takes at least 6 hours in transfected cells. (24) In our previous experiments, we compared transfection efficiency in Hep G 2 cells between PLNP and Lipofectamine by luciferase activity and cytotoxicity, and found that PLNP is less toxic than Lipofectamine in primary hepatocytes, and displayed transfection efficiency in Hep G 2 cells similar to Lipofectamine.(6) The automated fluorescence microscopy imaging system offers the possibility to dynamically monitor the transfection process in live cells, and we noticed that the earliest GFP appearance was within one hour in Hep G 2 cells transfected with PLNP, and a relatively faint GFP image was also seen in Hep G 2 cells transfected with Lipofectamine 20 minutes later. Thereafter, the intensity and spread of GFP were similar in cells transfected by either PLNP or Lipofectamine. Thus, we were able to dynamically monitor an early lipofection process in live cells over time. The time-lapsed imaging mode of the automated fluorescence deconvolution microscope minimizes long-term photobleaching by rapidly shuttering the excitation source on and off. The detection is based on a digital thermoelectrically cooled CCD camera, which enables us to quantitatively and dynamically determine GFP fluorescence (i.e. expression) levels in the cytoplasm over time. When specific dyes are used to indicate subcellular organelles, the DVDM system also allows to detect multiple, different colored fluorescence signals simultaneously from cells with high sensitivity together with their morphology in three dimensions without damaging cells. (9) The supplemental figure is an example of thus application. With this system, it is possible to investigate at specific time point which subcellular organelles are involved in the lipofection process, and critical events, such as intracellular trafficking of plasmid DNA, interaction or synchronization of multiple subcellular organelles.
One of the critical features of cationic lipid, polymers, lipid nanoparticles, lipoplexes or polyplexes is the Zeta potential, which reflects charge force for nucleotide binding. Both size distribution and Zeta potential may change after the formation of complexes with plasmid DNA. These two are important parameters of polyplex stability, and are even more critical when polyplexes are used for in vivo gene transfer. When forming polyplexes, the charge ratio will be a key factor affecting both Zeta potential and transfection efficiency. (25) A high Zeta potential often benefits in vitro transfection, whereas, neutral or negative Zeta potential of lipoplexes or polyplexes may have less serum reactivity, and is beneficial for complex stability in the bloodstream. (25, 26) When similar transfection efficiency is reached, a lower charge ratio (positive charge from cationic lipid over negative charge in DNA) indicates that less cationic lipid is needed for maximal plasmid DNA binding, which indicates the carrying capacity of specific lipids. We have previously shown that our PLNP formulation exhibited similar transfection efficiency when the charge ratio was changed from 1:3 to 1:5, indicating higher DNA binding and carrying capacity of this formulation.(6) In the present study, we found that the Zeta potential was reduced to be neutral or even negative when the charge ratio was decreased to a range from 1.25 to 1, and the data indicate that this charge ratio is beneficial for in vivo delivery through intravenous administration because it may have less reactivity to negatively charged serum proteins. This is a key issue that is under-addressed in the field of lipofection. The net positive charge of polyplexes or lipoplexes is the principal reason for the formation of large aggregates after intravenous administration of lipoplexes or polyplexes and may affect tissue distribution and gene transfer efficacy in specific organs, such as livers when non-viral lipid nanoparticles are used as gene transfer vectors.(27) The microscopic morphology of PLNP and polyplexes, as shown in Fig. 7 , further confirmed the stability after complexation with plasmid DNA, and there is a striking contrast to the formation of large aggregates of Lipofectamine-derived lipoplexes. Therefore, our PLNP are useful for both in vitro and in vivo gene transfer as demonstrated in our previous studies and may also be useful in delivering siRNA, similar to other cationic lipid nanoparticles. (28) In summary, the employment of novel state-of-the-art technologies in the study of lipofection represents the level of physico-chemical and biological characterization that is needed to best understand the key elements involved in the lipofection process. In the present study, we have described a refined method of PCL synthesis on a multigram scale. The data demonstrates that the morphology of PLNP derived from PCL did not change significantly after interaction with plasmid DNA, which is in striking contrast to the formation of large aggregates when using Lipofectamine. The large DNA carrying capacity allows PLNP to be saturated with negatively charged plasmid DNA, and the negative Zeta potential of PLNP-derived polyplexes is beneficial for in vivo stability. The Raman spectral signatures of PCL, PLNP and polyplexes reflect the polymeric nature of PLNP and the close interaction of PLNP with plasmid DNA. These data are in concordance with the good stability observed for PLNP in the bloodstream and the higher transfection efficiency in vivo compared to other formulations of lipid nanoparticles. Fig. 1 PCL synthetic 
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